Rmb Capital Management, LLC Aerie Pharmaceuticals Inc Transaction History

Rmb Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$11.84 - $25.52 $616,508 - $1.33 Million	-52,070 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.72 - $25.1 $728,469 - $1.03 Million	-41,110 Reduced 44.12%	52,070 $1.26 Million
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $1.72 Million - $2.61 Million	93,180 New	93,180 $1.79 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.